PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced the introduction of GlueSEEKER™. The new phenotypic screening platform...
Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNA®), announced its acquisition of...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Cogent Biosciences, Inc. a biotechnology company focused on developing precision therapies for genetically defined diseases, announced the appointment of Cole Pinnow as Chief Commercial Officer....
Providence Therapeutic Holdings Inc., a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines and therapeutics, and the Ontario...
